Successful use of extracorporeal membrane oxygenation for life‐threatening macrophage activation syndrome after treatment with tocilizumab in an systemic juvenile idiopathic arthritis patient

• Asıl Yazarlar: Xi Yang (Yazar), Yingfu Chen (Yazar), Rongxin Dai (Yazar), Yunfei An (Yazar), Xin Yan (Yazar), Xiaodong Zhao (Yazar), Xuemei Tang (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Wiley, 2023-12-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Abstract Macrophage activation syndrome (MAS) is a rare, potentially life‐threatening condition in rheumatic diseases. The primary treatments consist of high‐dose corticosteroids and immunosuppressive drugs, although more recently, cytokine inhibitors like anakinra or tocilizumab (TCZ) have been rep...